ClinVar Miner

Submissions for variant NM_000455.5(STK11):c.711C>A (p.Asp237Glu)

dbSNP: rs1057520379
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 1
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Ambry Genetics RCV001026060 SCV001188369 likely pathogenic Hereditary cancer-predisposing syndrome 2019-05-21 criteria provided, single submitter clinical testing The p.D237E variant (also known as c.711C>A), located in coding exon 5 of the STK11 gene, results from a C to A substitution at nucleotide position 711. The aspartic acid at codon 237 is replaced by glutamic acid, an amino acid with highly similar properties. This alteration is detected in an individual with clinical features of Peutz-Jeghers syndrome. Another alteration at this amino acid position, p.D237H, was reported in a patient with Peutz-Jeghers Syndrome and based on internal structural assessment, this alteration results in structural disruption in a sensitive region of the STK11 protein (Ambry internal data). This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis. Based on the majority of available evidence to date, this variant is likely to be pathogenic..

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.